XML 69 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Taxation (Tables)
12 Months Ended
Dec. 31, 2023
Taxation [Abstract]  
Schedule of Income Tax Expense The components of income before income taxes are as follows (in thousands):
   For the years ended December 31, 
   2021   2022   2023 
   RMB   RMB   RMB 
Loss before income tax expense            
Loss from Chinese mainland operations   (132,584)   (74,843)   (149,818)
Loss from non-Chinese mainland operations   (14,399)   (16,700)   (10,135)
Total Loss before income tax expense from continuing operations   (146,983)   (91,543)   (159,953)
Income tax benefit applicable to Chinese mainland operations               
Deferred tax   525    525    525 
Subtotal income tax benefit applicable to Chinese mainland operations   525    525    525 
Non-Chinese mainland withholding tax expense   (3)   (4)   (162)
Total income tax benefit from continuing operations   522    521    363 
Schedule of Reconciliation Between the Income Tax Credit Reconciliation between the income tax credit computed by applying the Enterprise Income Tax (“EIT”) rate to loss before income taxes and actual provision were as follows:
   For the years ended December 31, 
   2021   2022   2023 
   RMB   RMB   RMB 
Loss before income tax   (146,983)   (91,543)   (159,953)
Tax benefit at EIT tax rate of 25%   (36,746)   (22,886)   (39,989)
Effect of different tax rates applicable to different subsidiaries of the Group   (3,651)   241    18,589 
Effect of changes in tax rates   
-
    
-
    8,158 
Expired operating loss   
-
    
-
    14,966 
Permanent differences   (931)   (2,822)   13,722 
Changes in deferred tax assets valuation allowance   40,806    24,946    (15,809)
Income tax credit   (522)   (521)   (363)
Schedule of Operating Tax Loss Carry Forwards As of December 31, 2023, certain entities of the Group had net operating tax loss carry forwards as follows:
   For the year ended
December 31,
 
   2023 
    RMB 
Loss expiring in 2024   125,177 
Loss expiring in 2025   4,538 
Loss expiring in 2026   137,657 
Loss expiring in 2027   61,233 
Loss expiring in 2028   2,473 
Loss expiring in 2029   356 
Loss expiring in 2030   85,329 
Loss expiring in 2031   51,726 
Loss expiring in 2032   29,854 
Loss expiring in 2033   112,537 
    610,880 

 

Schedule of Deferred Tax Assets and Liabilities The following table presents the tax impact of significant temporary differences that give rise to the deferred tax assets and liabilities as of December 31, 2022 and 2023:
   December 31,
2022
   December 31,
2023
 
   RMB   RMB 
Deferred tax assets:        
Net accumulated losses carry forwards   140,950    124,740 
Accrued payroll and other expenses   7,570    9,480 
Advertising expenses in excess of deduction limit   9,841    6,500 
 Fair value changes of amounts due to related party   3,108    4,237 
Accrued expenses   400    427 
Deferred revenue   358    358 
Others   1,006    1,682 
Deferred tax assets   163,233    147,424 
Less: valuation allowance   (163,233)   (147,424)
Deferred tax assets, net   
-
    
-
 
Deferred tax liabilities:          
Identifiable intangible assets arising from acquisition of Cheche Insurance (Note 7)   (2,538)   (2,013)
Deferred tax liabilities   (2,538)   (2,013)
Schedule of Valuation Allowances the Related Deferred Tax Assets The following table sets forth the movement of valuation allowance for the years presented:
   December 31,
2021
   December 31,
2022
   December 31,
2023
 
   RMB   RMB   RMB 
Balance at the beginning of the year   (97,481)   (138,287)   (163,233)
(Additions)/Reversals   (40,806)   (24,946)   15,809 
Balance at end of the year   (138,287)   (163,233)   (147,424)